PARTNERSHIPS AND COLLABORATIONS

Food and Drug Administration

http://www.fda.gov

CDP has monthly meetings with the Center for Diagnostics and Regulatory Health at FDA and the DCTD Cancer Therapy Evaluation Program at which markers/assays proposed for clinical trials are discussed. In addition, appropriate regulatory issues for multi-analyte assays, such as genomics, are also discussed in order to understand issues that could impede development of these assays.